20
Concord Biotech Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MUPIROCIN USP, with a corresponding US DMF Number 28618.
Remarkably, this DMF maintains an Active status since its submission on October 08, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 28, 2014, and payment made on October 08, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II